
Fujifilm to establish its first Bio-CDMO site in Japan Accelerating business growth of the life sciences field and contributing to the strengthening of domestic vaccine production in Japan
News Release
October 6, 2022
Print
TOKYO, October 6, 2022 - FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) today announces that it will establish the company's first Japanese Bio-CDMO site in Toyama City, Toyama Prefecture. The new site will be invested by FUJIFILM Toyama Chemical and will be operational in FY2026.
The Japanese Government is currently promoting the strengthening of domestic vaccine production to prepare against future pandemics. As part of this effort, the Japanese Government supports projects such as establishing sites with dual-use facilities capable of producing biopharmaceuticals to meet customer needs during normal times and switching to vaccine production during a pandemic. Fujifilm's investment has been selected for the project of Developing biopharmaceutical manufacturing sites to strengthen vaccine production promoted by the Ministry of Economy, Trade and Industry in Japan*1.
Fujifilm currently operates its own Bio-CDMO business globally, as well as drug discovery, development and manufacturing support, and offering culture media, cells and research reagents through a company-wide strategy led Fujifilm's Life Sciences Strategy Headquarters. By leveraging Fujifilm's global manufacturing sites and sales networks, the company has been expanding its business in the life sciences field mainly in Europe and the United States.
In order to expand business in the fast-growing Asian market, Fujifilm will establish a Bio-CDMO site equipped with dual-use facilities in Japan, operated by FUJIFILM Toyama Chemical in close collaboration with other Fujifilm Life Sciences entities. It will apply advanced biotechnologies and know-how nurtured through Fujifilm's global business, which enables offering high-quality CDMO services. When an outbreak of infectious disease evolves into a pandemic, the site will strongly support pharmaceutical companies for development and delivery of domestic vaccines.
With this strategic investment, Fujifilm will strongly support customers in the biopharmaceutical industry and accelerate business growth of the life sciences field , said Teiichi Goto, president and chief executive officer, representative director, FUJIFILM Corporation. We hope the new site will play an important role in the Japanese Government's initiative to strengthen vaccine production, thereby contributing to the health and well-being in Japan and other Asian countries.
Overview of the new site
1.Features
The manufacturing site of FUJIFILM Toyama Chemical will be equipped with the facilities capable of development of manufacturing process of biopharmaceuticals. In addition, new buildings for investigational drug manufacturing and commercial production of biopharmaceuticals will be constructed in the site.
The site will feature dual-use facilities capable of manufacturing biopharmaceuticals such as antibody drugs and antibody drug conjugates (ADC*2) and switching to manufacturing mRNA vaccines and genetically-engineered protein vaccines during pandemic. The site will be able to provide end-to-end services from drug substance production, through to fill-finish and final packing.
The site will be applied with the cutting-edge biotechnologies including cell culture and purification technologies and genetic engineering technology of FUJIFILM Diosynth Biotechnologies, a group company with over 30 years of experience as a Bio-CDMO offering services for broad range of biopharmaceuticals. These technologies will facilitate high-efficiency production, enabling fast and stable supply of high-quality biopharmaceuticals.
Fujifilm will offer comprehensive Bio-CDMO services to clients, through close collaboration between FUJIFILM Toyama Chemical, FUJIFILM Diosynth Biotechnologies and FUJIFILM Wako Pure Chemical.
2.Operational timing
in FY2026 ending March 2027
*1 The grant amount will be determined in FY2023 ending March 2024.
*2 ADC is a class of biopharmaceutical agent that combines a drug such as an anti-cancer agent with antibodies. The antibodies in ADC bind with antigens present on the surface of cancer cells to enable targeted delivery of a drug. Due to this mechanism, ADC is expected to provide a greater treatment effect with less side effects.
Contact
Media Contact
FUJIFILM Holdings Corporation
Corporate Communications Division,
Public Relations Group
TEL +81-3-6271-2000
* Please note that the contents including the product availability, specification, prices and contacts in this website are current as of the date of the press announcement and may be subject to change without prior notice.
More from Fujifilm
23/01/2023
Fujifilm UK looks to boost wide format market presence with the appointment of n...
19/01/2023
Fujifilm Europe supports World Cancer Day
January 19, 2023
Print
Fujifilm Europe has announced its partnership with World Cancer Day, an initiative led by...
10/01/2023
Fujifilm continues to expand packaging team with new recruits in Italy and Spain New appointments will help to boost Fujifilm's packaging product sales ac...
06/01/2023
FUJIFILM Cellular Dynamics Announces License Agreement with Novo Nordisk for the...
06/01/2023
Thousands of photos from across Europe capture precious and special memories for...
05/01/2023
Fujifilm Announces Addition of Splatoon 3 and Other Unique Features in the Upda...
26/12/2022
Fujifilm and Utilization of Carbon Dioxide Institute sign a joint research agree...
21/12/2022
Fujifilm to open FUJIFILM Creative Village in Tokyo The new base for Fujifilm Group's design and IT development Designers and IT engineers exerting their ...
19/12/2022
Fujifilm Announces Asset Purchase Agreement with Inspirata, Inc. to acquire the ...
16/12/2022
Sustainable solutions at the heart of Fujifilm House' In October 2022, Fujifilm officially opened Fujifilm House', its new UK headquarters in Bedfor...
08/12/2022
Fujifilm announces new print mode and greater flexibility for Jet Press 750S Hig...
06/12/2022
Aztec Label invest in Fujifilm's Activ LED UV curing system to achieve lower...
24/11/2022
Fujifilm announces a change to its offset plate manufacturing in EMEA
November 24, 2022
Print
Fujifilm today announces the closure of the company's of...
22/11/2022
Red Sky Foundation and Fujifilm join forces to help little hearts and their fami...
07/11/2022
IPE Industria Gr fica invests in the future with Activ LED curing system from Fu...
02/11/2022
Introducing the FUJIFILM X-T5 Offering a compact and lightweight body, a host of new features and superior image quality:
November 2, 2022
Print
Fujifilm...
02/11/2022
Introducing the FUJINON XF30mmF2.8 R LM WR Macro Offering macro photography at a 1:1 magnification ratio
Latest lens to join the range boasts a compact, lig...
02/11/2022
Fujifilm to showcase the full capabilities of its wide format range at event hos...
01/11/2022
Fujifilm Europe appoints Ralf Petersen as Workflow & Solution Consultant, Packag...
27/10/2022
Fujifilm's New INSTAX SQUARE Link Smartphone Printer brings Augmented Realit...
27/10/2022
Fujifilm announces availability of its Revoria range in Switzerland Fujifilm's Revoria Press PC1120 and E1 series toner presses are now available in Switz...
26/10/2022
Vario Press Ltd adds Fujifilm Acuity Prime to its portfolio The UK print and marketing agency has witnessed an increase in production speeds following their i...
24/10/2022
Floricolor expands business offering and increases revenue with investment in Fu...
21/10/2022
Fujifilm UK opens new strategic headquarters in Bedford New sustainability-focused HQ for Fujifilm UK - graded BREEAM Excellent' - is officially opened w...
20/10/2022
Fujifilm announces joint development with Barber n to bring high quality, single...
07/10/2022
Nineteen products in a wide range of categories win Good Design Award - Fujifilm picks up the largest number of awards for four consecutive years
- Medical ...
06/10/2022
Fujifilm to establish its first Bio-CDMO site in Japan Accelerating business growth of the life sciences field and contributing to the strengthening of domest...
28/09/2022
FUJIFILM Dimatix Supports OEMs with New STARFIRE Printheads for Printing with E...
26/09/2022
FUJIFILM Sonosite announces the European launch of Sonosite LX, the industry lea...
14/09/2022
Fujifilm further invests USD 20 million in next-generation battery company, 24M ...
13/09/2022
Premista Series of zoom lenses for cinema cameras wins Silver in the internation...
12/09/2022
FUJIFILM Diosynth Biotechnologies breaks ground on a USD 1.6 billion (11 billio...
05/09/2022
Fujifilm unveils expanded pulmonology solutions portfolio with addition of new s...
31/08/2022
VISION 2022: FUJIFILM presents heavy-duty lens series HF-XA-1F At the world leading machine vision show, FUJIFILM showcases its industrial lens lineup with ou...
26/08/2022
Lights, Cameras, Dissertations! Fujifilm present prize for highest mark in Resea...
10/08/2022
FUJIFILM Corporation's instax and Undisputed announce strategic partnership ...
02/08/2022
Fujifilm appoints Shaun Holdom as Marketing Manager - Wide Format Inkjet Systems In his new role, Holdom will spearhead the marketing strategy for the Acuity ...
01/08/2022
Fujifilm Europe appoints Raynald Barillot as Category Manager, Digital Packaging...
01/08/2022
Printlife@home, Fujifilms initiative to spread a mass culture of printed photogr...
27/07/2022
Fujifilm announces the adoption of the ADRA, an alternative method for skin sens...
21/07/2022
Fujifilm to launch two new NURA health screening centers focusing on cancer scre...
21/07/2022
Fujifilm collaborates with The Equinox Group and Fokina to create show-stopping ...
19/07/2022
Fujifilm Europe appoints Dr. Karl Borsky as Category Manager, Analogue Packaging...
13/07/2022
Fujifilm integrates AI software to help identify bone trauma at POC (Point-of-Ca...
13/07/2022
Fujifilm Europe launches new hybrid C-arm and portable x-ray device
July 13, 2022
Print
FDR CROSS is a flexible, hybrid C-arm and portable x-ray machine d...
12/07/2022
Fujifilm Europe officially open new strategic European Headquarters
July 12, 2022
Print
Teiichi Goto, President & CEO of FUJIFILM Holdings Corporation, Mo...
07/07/2022
Scribbler & FUJIFILM partner to offer exclusive game-changing' instant gree...
07/07/2022
Fujifilm launches Jet Press Connector app for Enfocus Switch
July 7, 2022
Print
Fujifilm has developed the Fujifilm Jet Press Connector app for Enfocus Sw...